JP4727227B2 - ケイ酸含有押出物の製造方法、前記押出物、その使用、及び前記押出物を含む医薬組成物 - Google Patents

ケイ酸含有押出物の製造方法、前記押出物、その使用、及び前記押出物を含む医薬組成物 Download PDF

Info

Publication number
JP4727227B2
JP4727227B2 JP2004528493A JP2004528493A JP4727227B2 JP 4727227 B2 JP4727227 B2 JP 4727227B2 JP 2004528493 A JP2004528493 A JP 2004528493A JP 2004528493 A JP2004528493 A JP 2004528493A JP 4727227 B2 JP4727227 B2 JP 4727227B2
Authority
JP
Japan
Prior art keywords
extrudate
silicic acid
choline
acid
stabilized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2004528493A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005535549A5 (cg-RX-API-DMAC7.html
JP2005535549A (ja
Inventor
ディルク・アンドレ・リチャード・ヴァンデン・バーグ
Original Assignee
バイオミネラルズ・エヌ・ヴェー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バイオミネラルズ・エヌ・ヴェー filed Critical バイオミネラルズ・エヌ・ヴェー
Publication of JP2005535549A publication Critical patent/JP2005535549A/ja
Publication of JP2005535549A5 publication Critical patent/JP2005535549A5/ja
Application granted granted Critical
Publication of JP4727227B2 publication Critical patent/JP4727227B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/28—Silicates, e.g. perlites, zeolites or bentonites
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/20—Shaping or working-up of animal feeding-stuffs by moulding, e.g. making cakes or briquettes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/25—Shaping or working-up of animal feeding-stuffs by extrusion
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/015—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/20—Agglomerating; Granulating; Tabletting
    • A23P10/25—Agglomeration or granulation by extrusion or by pressing, e.g. through small holes, through sieves or between surfaces
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Animal Husbandry (AREA)
  • Nutrition Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
JP2004528493A 2002-08-12 2003-08-12 ケイ酸含有押出物の製造方法、前記押出物、その使用、及び前記押出物を含む医薬組成物 Expired - Lifetime JP4727227B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02078336A EP1391426A1 (en) 2002-08-12 2002-08-12 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate
EP02078336.1 2002-08-12
PCT/EP2003/009009 WO2004016551A1 (en) 2002-08-12 2003-08-12 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010178022A Division JP2010265309A (ja) 2002-08-12 2010-08-06 ケイ酸含有押出物の製造方法、前記押出物、その使用、及び前記押出物を含む医薬組成物

Publications (3)

Publication Number Publication Date
JP2005535549A JP2005535549A (ja) 2005-11-24
JP2005535549A5 JP2005535549A5 (cg-RX-API-DMAC7.html) 2010-01-07
JP4727227B2 true JP4727227B2 (ja) 2011-07-20

Family

ID=30775855

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004528493A Expired - Lifetime JP4727227B2 (ja) 2002-08-12 2003-08-12 ケイ酸含有押出物の製造方法、前記押出物、その使用、及び前記押出物を含む医薬組成物
JP2010178022A Pending JP2010265309A (ja) 2002-08-12 2010-08-06 ケイ酸含有押出物の製造方法、前記押出物、その使用、及び前記押出物を含む医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010178022A Pending JP2010265309A (ja) 2002-08-12 2010-08-06 ケイ酸含有押出物の製造方法、前記押出物、その使用、及び前記押出物を含む医薬組成物

Country Status (15)

Country Link
US (2) US8771757B2 (cg-RX-API-DMAC7.html)
EP (2) EP1391426A1 (cg-RX-API-DMAC7.html)
JP (2) JP4727227B2 (cg-RX-API-DMAC7.html)
CN (2) CN101829143A (cg-RX-API-DMAC7.html)
AT (1) ATE428404T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003266283B2 (cg-RX-API-DMAC7.html)
CA (1) CA2494165C (cg-RX-API-DMAC7.html)
CY (1) CY1109228T1 (cg-RX-API-DMAC7.html)
DE (1) DE60327231D1 (cg-RX-API-DMAC7.html)
DK (1) DK1551763T3 (cg-RX-API-DMAC7.html)
ES (1) ES2325254T3 (cg-RX-API-DMAC7.html)
IL (2) IL166779A0 (cg-RX-API-DMAC7.html)
PT (1) PT1551763E (cg-RX-API-DMAC7.html)
SI (1) SI1551763T1 (cg-RX-API-DMAC7.html)
WO (1) WO2004016551A1 (cg-RX-API-DMAC7.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1391426A1 (en) 2002-08-12 2004-02-25 Bio Minerals N.V. Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate
ITMI20050093A1 (it) * 2005-01-25 2006-07-26 Unimer Spa Procedimento industriale per ottenere la granulazione di fertilizzanti mangimi e altri prodotti a partire da un procedimento preliminare di pellettatura
US7700083B2 (en) * 2005-10-24 2010-04-20 Kevin Meehan Skin care composition for accelerated production of collagen proteins and method of fabricating same
FR2909558B1 (fr) * 2006-12-12 2009-04-17 Ceva Sante Animale Sa Procede de fabrication de premelanges medicamenteux
ES2652114T3 (es) * 2007-10-15 2018-01-31 7 Oaks Pharmaceutical Corporation Una disolución que contiene silicato para uso en el tratamiento de melanoma
GB0720423D0 (en) * 2007-10-19 2007-11-28 Univ Leuven Kath Method for brewing beer
GB0805279D0 (en) 2008-03-20 2008-04-30 Univ Nottingham Trent Food supplement
WO2009127256A1 (en) * 2008-04-17 2009-10-22 Jisbrey, S.A Hydronium stabilized and dissoluble silicic acid nanoparticles: preparation, stabilization and use
CZ2008841A3 (cs) * 2008-12-23 2010-07-28 Agra Group, A.S. Pivo a nápoje na bázi piva a zpusob úpravy obsahu polyfenolu a kremíku v nich
GB0913255D0 (en) 2009-07-30 2009-09-02 Sisaf Ltd Topical composition
DE102010008981A1 (de) * 2010-02-24 2011-08-25 Bayer Innovation GmbH, 40225 Siliciumhaltiges, biologisch degradierbares Material zur pro-angiogenetischen Therapie
DE102010008982A1 (de) 2010-02-24 2011-08-25 Bayer Innovation GmbH, 40225 Siliciumhaltiges, biologisch degradierbares Material zur anti-inflammatorischen Therapie
WO2012032364A1 (en) 2010-09-06 2012-03-15 Creogen D.O.O. Stabilized solution of ortho-silicic acid based on salicylic acid as effective inhibitor of its polymerization, its preparation and use
WO2012035364A1 (en) 2010-09-15 2012-03-22 Creogen D.O.O. Stabilized solution of ortho-silicic acid, its preparation and use
US10986647B2 (en) 2017-05-04 2021-04-20 At&T Intellectual Property I, L.P. Management of group common downlink control channels in a wireless communications system
CN107988292B (zh) * 2018-01-18 2023-12-26 江苏江山聚源生物技术有限公司 提高重组人源胶原蛋白稳定性的发酵工艺
EP3549578A1 (en) * 2018-04-06 2019-10-09 Bio Minerals N.V. Silicic acid formulation and use thereof
EP3632449A1 (en) 2018-10-05 2020-04-08 Bio Minerals N.V. Silicic acids for use in the treatment of periodontitis
EP3650011A1 (en) * 2018-11-09 2020-05-13 Bio Minerals NV Water soluble silicon-containing granulate
PL3662761T3 (pl) * 2018-12-04 2021-11-02 Dsm Ip Assets B.V. Stabilne podczas przechowywania adsorbaty związków nitrooksy
EP3714879A1 (en) 2019-03-28 2020-09-30 Sisaf Ltd Structured encapsulated silicon-containing particles
GB201904337D0 (en) 2019-03-28 2019-05-15 Sisaf Ltd A delivery system
GB201904334D0 (en) 2019-03-28 2019-05-15 Sisaf Ltd Carrier system for preparing herbaceous extracts
GB201904336D0 (en) 2019-03-28 2019-05-15 Sisaf Ltd A delivery system
WO2020260413A1 (fr) 2019-06-28 2020-12-30 Tilman Sa Composition comprenant au moins un triterpène et/ou au moins un triterpénoïde et/ou au moins une de leurs formes glycosylées
GB202104173D0 (en) * 2021-03-24 2021-05-05 Ab Vista Animal feed composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9400189A (nl) 1994-02-07 1995-09-01 Bio Pharma Sciences Bv Gestabiliseerd orthosiliciumzuur bevattend preparaat, een werkwijze voor het bereiden daarvan en een biologisch preparaat.
FR2799758B1 (fr) * 1999-10-15 2002-05-17 Exsymol Sa Complexe a base d'acide orthosilicique biologiquement assimilable, se presentant sous forme solide, stable et concentree, et procede de preparation
EP1110909A1 (en) * 1999-12-24 2001-06-27 Bio Minerals N.V. Method for preparing ortho silicic acid, ortho silicic acid as obtained, and its use
EP1391426A1 (en) 2002-08-12 2004-02-25 Bio Minerals N.V. Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate

Also Published As

Publication number Publication date
US20060099276A1 (en) 2006-05-11
AU2003266283A1 (en) 2004-03-03
CA2494165A1 (en) 2004-02-26
CN101829143A (zh) 2010-09-15
US20140255493A1 (en) 2014-09-11
US8945617B2 (en) 2015-02-03
EP1391426A1 (en) 2004-02-25
CN1678524A (zh) 2005-10-05
DE60327231D1 (de) 2009-05-28
SI1551763T1 (sl) 2009-10-31
WO2004016551A1 (en) 2004-02-26
CY1109228T1 (el) 2014-07-02
EP1551763B1 (en) 2009-04-15
JP2010265309A (ja) 2010-11-25
US8771757B2 (en) 2014-07-08
PT1551763E (pt) 2009-07-07
AU2003266283B2 (en) 2008-04-10
EP1551763A1 (en) 2005-07-13
ES2325254T3 (es) 2009-08-31
DK1551763T3 (da) 2009-07-20
JP2005535549A (ja) 2005-11-24
CA2494165C (en) 2009-05-26
IL166779A (en) 2010-05-17
ATE428404T1 (de) 2009-05-15
IL166779A0 (en) 2006-01-15

Similar Documents

Publication Publication Date Title
JP2010265309A (ja) ケイ酸含有押出物の製造方法、前記押出物、その使用、及び前記押出物を含む医薬組成物
AU783216B2 (en) Method for preparing ortho silicic acid, ortho silicic acid as obtained, and its use
JP2005535549A5 (cg-RX-API-DMAC7.html)
CA2435888A1 (en) Method of preparing biological materials and preparation produced using same
CN1104890A (zh) 阳离子络合的多糖
JPH09505564A (ja) 動物のための経口投与される投与形態、その調製方法およびその使用
KR20030081489A (ko) 당알콜을 함유하는 분무건조 분말의 용도
TW202028330A (zh) 水溶性含矽顆粒
JPWO2005025609A1 (ja) ラクトフェリン素材組成物
AU2019247705B2 (en) Silicic acid formulation and use thereof
JP6891113B2 (ja) アルギニンを高含有する錠剤
JPH0678226B2 (ja) 脱水医薬品とその製造方法
CN121400581A (zh) 酶解法制备高活性海洋生物肽及其在食品中的应用
JP2022121348A (ja) シアル酸誘導物質含有剤含有製剤、及び、シアル酸誘導物質含有剤含有製剤の製造方法
EA046569B1 (ru) Композиция кремниевой кислоты и ее применение
HK40042704A (en) Silicic acid formulation and use thereof
CN1747717A (zh) 包含多糖组分和一个或多个涂层的组合物

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060509

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090512

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090804

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090811

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20091112

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100406

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100806

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20100806

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20100928

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101130

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101201

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110315

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110413

R150 Certificate of patent or registration of utility model

Ref document number: 4727227

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140422

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term